← MEDIFAST INC MED
Market Price
$11.43
Market Cap
$127.65M
P/E Ratio
N/A
Revenue (FY 2025)
↓-36.0% YoY
$385.79M
3-Yr CAGR: -37.7%
Net Income
↓-993.0% YoY
-$18.67M
Net Margin: -4.8%
Free Cash Flow
↓-92.7% YoY
$1.25M
FCF Yield: 0.98%
EPS (Diluted)
↓-994.7% YoY
$-1.70
Basic: $-1.70
Return on Equity
Efficiency
-9.4%
ROA: -206.0%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (MED)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $274.5M | — | $205.7M | $17.8M | — | $1.49 | — | $25.4M | $22.5M | — |
| FY 2017 | $301.6M | +9.8% | $227.8M | $27.7M | +55.4% | $2.29 | +53.7% | $43.2M | $40.0M | +78.0% |
| FY 2018 | $501.0M | +66.1% | $379.9M | $55.8M | +101.3% | $4.62 | +101.7% | $60.8M | $55.9M | +39.7% |
| FY 2019 | $713.7M | +42.4% | $536.9M | $77.9M | +39.7% | $6.43 | +39.2% | $84.3M | $74.2M | +32.8% |
| FY 2020 | $934.8M | +31.0% | $697.8M | $102.9M | +32.0% | $8.68 | +35.0% | $145.2M | $139.3M | +87.7% |
| FY 2021 | $1,526.1M | +63.2% | $1,127.6M | $164.0M | +59.5% | $13.89 | +60.0% | $94.5M | $60.3M | -56.7% |
| FY 2022 | $1,598.6M | +4.8% | $1,140.4M | $143.6M | -12.5% | $12.73 | -8.4% | $194.6M | $177.9M | +194.8% |
| FY 2023 | $1,072.1M | -32.9% | $775.9M | $99.4M | -30.8% | $9.10 | -28.5% | $147.7M | $141.2M | -20.6% |
| FY 2024 | $602.5M | -43.8% | $444.6M | $2.1M | -97.9% | $0.19 | -97.9% | $24.5M | $17.0M | -87.9% |
| FY 2025 | $385.8M | -36.0% | $275.2M | $-18.7M | -993.0% | $-1.70 | -994.7% | $6.9M | $1.2M | -92.7% |
Valuation
Market Price
$11.43
Market Cap
$127.65M
Enterprise Value
N/A
P/E Ratio
N/A
P/B Ratio
0.64
FCF Yield
0.98%
Dividend Yield
0.00%
Shares Outstanding
Profitability & Margins
Gross Margin
71.33%
Operating Margin
-3.68%
Net Margin
-4.84%
Return on Equity (ROE)
-9.39%
Return on Assets (ROA)
-205.96%
Asset Turnover
42.55x
Revenue 3-Yr CAGR
-37.74%
Financial Health & Liquidity
Current Ratio
0.21
Cash Ratio
2.08
Debt / Equity
N/A
Debt / Assets
N/A
Cash & Equivalents
$89.30M
Total Debt
N/A
Book Value / Share
$17.89
Cash Flow Efficiency
Operating Cash Flow
$6.86M
Capital Expenditures (CapEx)
$5.61M
Free Cash Flow
$1.25M
OCF / Revenue
1.78%
FCF / Revenue
0.32%
FCF 3-Yr CAGR
-80.85%
Per Share Metrics
EPS (Diluted)
$-1.70
EPS (Basic)
$-1.70
Dividends / Share
N/A
Book Value / Share
$17.89
EPS YoY Growth
-994.74%
Balance Sheet (FY 2025)
Total Assets
$9.07M
Total Liabilities
$42.96M
Stockholders' Equity
$198.92M
Current Assets
$9.07M
Current Liabilities
$42.96M